期刊文献+

腹膜透析并发感染性腹膜炎患者血清降钙素原检测的临床意义 被引量:8

Clinical significance of serum procalcitonin in patients with peritoneal dialysis complicated with infectious peritonitis
原文传递
导出
摘要 目的探讨血清降钙素原(PCT)对腹膜透析相关性腹膜炎患者的诊断、疗效观察中的应用价值。方法检测30例腹膜透析相关性腹膜炎患者和30例腹膜透析无相关性腹膜炎患者为对照组,检测血清PCT、C-反应蛋白(CRP)、白细胞(WBC)的浓度,并动态观察以上各指标在腹膜透析相关性腹膜炎患者治疗前后的变化。结果 PCT与CRP治疗前后比较差异有统计学意义(P<0.05);WBC治疗前后变化不明显(P>0.05)。结论 CRP、PCT是诊断腹膜透析相关性腹膜炎的较好指标;CRP与PCT在腹膜透析相关性腹膜炎患者经有效抗感染治疗后均可发生显著变化,联合检测CRP和PCT对腹膜透析相关性腹膜炎的疗效观察具有重要的临床意义。 Objective To investigate the application value of serum procaleitonin(PCT) on diagnosis and efficacy observation of continuous ambulatory peritoneal dialysis patients with peritoneal dialysis-related peritonitis. Methods Thirty cases of contin- uous ambulatory peritoneal dialysis patients with peritoneal dialysis-related peritonitis and 30 cases of no PD-related peritonitis continuous ambulatory peritoneal dialysis were tested by PCT, C-reactive protein ( CRP), white blood cell (WBC)in 24 hours. The changes of above indexes were observed dynamically before and after the treatment of PD-related peritonitis. Results There were significant differences in PCT and CRP before after treatment ( P 〈 0.05 ) ; But there was no significant difference in WBC ( P 〉 0.05 ). Conclusion (1)PCT and CRP are helpful for diagnosing PD-related peritonitis ; (2)The combined detection of CRP and PCT on the efficacy of PD - related peritonitis has important clinical significance.
出处 《临床医学》 CAS 2012年第8期17-18,共2页 Clinical Medicine
关键词 降钙素原 C-反应蛋白 腹膜透析相关性腹膜炎 诊断 疗效监测 Serum procalcitonin C-reactive protein Peritoneal dialysis related peritonitis Diagnosis Efficacy monitoring
  • 相关文献

参考文献8

二级参考文献38

  • 1周人杰,肖颖彬,张国强.全反维甲酸对人肺癌细胞株A549细胞间黏附分子-1表达及体外侵袭力的影响[J].中国肿瘤生物治疗杂志,2004,11(4):291-292. 被引量:6
  • 2王瑾,张蓉,邵肖梅.降钙素原在新生儿感染中的应用价值[J].临床儿科杂志,2005,23(2):105-107. 被引量:57
  • 3周人杰,廖卫公,杨镇洲,戴纪纲,肖颖彬.全反式维甲酸联合三羟异黄酮对肺癌细胞增殖及凋亡的影响[J].第三军医大学学报,2006,28(11):1198-1200. 被引量:3
  • 4Reinhart K, Carlet J. Procalcitonin - a new marker of severe infection and sepsis [ J]. Intensive Care Med, 2000, 26( Suppl 2) : 145.
  • 5Szeto CC, Chow KM, Won TY,et al. Conservative management of polymicrobial peritonitis complicating peritoneal dialysis?a series of 140 consecutive cases. Am J Med, 2002, 113(9): 728-733.
  • 6Khairullah Q, Provenzano R, Tayeb J,et al. Comparison of vancomycin verse cefazolin as initial therapy for peritonitis in peritoneal dialysis patients. Perit Dial Int, 2002, 22(3): 339-344.
  • 7Baker RJ, Senior H, Clemenger M,et al. Empirical aminoglycosides for peritonitis do not affect residual renal function. Am J Kidney Dis, 2003, 41(3): 670-675.
  • 8Goffin E, Herbiet L, Pouthier D,et al. Vancomycin and ciprofloxacin: systemic antibiotic administration for peritoneal dialysis-associated peritonitis. Perit Dial Int, 2004, 24(5): 433-439.
  • 9Leung CB, Szeto CC, Chow KM,et al. Cefazolin plus ceftazidime versus imipenem/cilastatin monotherapy for the treatment of CAPD peritonitis-a randomized controlled trial. Perit Dial Int, 2004, 24(5): 440-446.
  • 10Williamson JC, Volles DF, Lynch PL,et al. Stability of cefepime in peritoneal dialysis solution. Ann Pharmacother, 1999, 33(9): 906-909.

共引文献143

同被引文献114

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部